These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34002042)

  • 1. Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage.
    Ling QS; Zhang SL; Tian JS; Cheng MH; Liu AJ; Fu FH; Liu JG; Miao CY
    Acta Pharmacol Sin; 2021 Jun; 42(6):871-884. PubMed ID: 34002042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double blind, placebo-controlled, multicenter phase II trial of Allisartan Isoproxil in essential hypertensive population at low-medium risk.
    Li Y; Li XH; Huang ZJ; Yang GP; Zhang GG; Zhao SP; Guo Y; Lu SJ; Ma JL; Meng FB; Chen P; Yuan H
    PLoS One; 2015; 10(2):e0117560. PubMed ID: 25693004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
    Wang P; Tang F; Li R; Zhang H; Chen S; Liu P; Huang H
    Pharmacol Res; 2007 May; 55(5):408-17. PubMed ID: 17324585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial.
    Zhang G; Fan Y; Qiu Y; Zhou Z; Zhang J; Wang Z; Liu Y; Liu X; Tao J
    Adv Ther; 2020 Aug; 37(8):3551-3561. PubMed ID: 32583313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats.
    Barone FC; Coatney RW; Chandra S; Sarkar SK; Nelson AH; Contino LC; Brooks DP; Campbell WG; Ohlstein EH; Willette RN
    Cardiovasc Res; 2001 Jun; 50(3):525-37. PubMed ID: 11376628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of allisartan, a new AT(1) receptor blocker, on blood pressure and end-organ damage in hypertensive animals.
    Wu MY; Ma XJ; Yang C; Tao X; Liu AJ; Su DF; Liu JG
    Acta Pharmacol Sin; 2009 Mar; 30(3):307-13. PubMed ID: 19262554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of allisartan isoproxil on blood pressure and target organ injury in patients with mild to moderate essential hypertension.
    Zhang JQ; Yang GH; Zhou X; Liu JX; Shi R; Dong Y; Chen SB; Li YM
    Medicine (Baltimore); 2019 Mar; 98(12):e14907. PubMed ID: 30896643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats.
    Nagura J; Hui C; Yamamoto M; Yasuda S; Abe M; Hachisu M; Konno F
    Jpn J Pharmacol; 1996 May; 71(1):39-49. PubMed ID: 8791170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allisartan ameliorates vascular remodeling through regulation of voltage-gated potassium channels in hypertensive rats.
    Zhang X; Zhao Z; Xu C; Zhao F; Yan Z
    BMC Pharmacol Toxicol; 2021 Jun; 22(1):33. PubMed ID: 34108047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Allisartan Isoproxil in the Treatment of Mild-to-Moderate Essential Hypertension.
    Wang H; Xi Y; Chen Y; Wang L; Yang F; Lu X; Sun N
    Am J Hypertens; 2023 Sep; 36(10):561-567. PubMed ID: 37343187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allisartan isoproxil attenuates oxidative stress and inflammation through the SIRT1/Nrf2/NF‑κB signalling pathway in diabetic cardiomyopathy rats.
    Jin Q; Zhu Q; Wang K; Chen M; Li X
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal.
    Fornes P; Richer C; Vacher E; Bruneval P; Giudicelli JF
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):305-13. PubMed ID: 7692174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dual angiotensin type 1 receptor/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat.
    Rubattu S; Cotugno M; Forte M; Stanzione R; Bianchi F; Madonna M; Marchitti S; Volpe M
    J Hypertens; 2018 Sep; 36(9):1902-1914. PubMed ID: 29916993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats.
    Rehman A; Leibowitz A; Yamamoto N; Rautureau Y; Paradis P; Schiffrin EL
    Hypertension; 2012 Feb; 59(2):291-9. PubMed ID: 22184324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
    Stier CT; Adler LA; Levine S; Chander PN
    J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotensive and prophylactic effects of angiotensin II subtype 1 receptor antagonist, irbesartan, in stroke-prone spontaneously hypertensive rats.
    Shimamura T; Masui M; Torii M; Nakajima M
    Clin Exp Hypertens; 2004 Jan; 26(1):27-42. PubMed ID: 15000295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prehypertension treatment with losartan effectively prevents brain damage and stroke in stroke-prone spontaneously hypertensive rats.
    He DH; Zhang LM; Lin LM; Ning RB; Wang HJ; Xu CS; Lin JX
    Int J Mol Med; 2014 Feb; 33(2):301-9. PubMed ID: 24337406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
    Nishikawa K
    J Hum Hypertens; 1998 May; 12(5):301-9. PubMed ID: 9655651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
    Inada Y; Wada T; Ojima M; Sanada T; Shibouta Y; Kanagawa R; Ishimura Y; Fujisawa Y; Nishikawa K
    Clin Exp Hypertens; 1997 Oct; 19(7):1079-99. PubMed ID: 9310205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
    Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
    Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.